Arkadios Wealth Advisors Has $1.30 Million Stake in GE HealthCare Technologies Inc. $GEHC

Arkadios Wealth Advisors boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 43.4% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,608 shares of the company’s stock after purchasing an additional 5,329 shares during the period. Arkadios Wealth Advisors’ holdings in GE HealthCare Technologies were worth $1,304,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Hotchkis & Wiley Capital Management LLC increased its holdings in GE HealthCare Technologies by 3.2% during the 1st quarter. Hotchkis & Wiley Capital Management LLC now owns 5,751,773 shares of the company’s stock valued at $464,226,000 after purchasing an additional 176,572 shares in the last quarter. JPMorgan Chase & Co. increased its holdings in GE HealthCare Technologies by 49.9% during the 1st quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock valued at $414,894,000 after purchasing an additional 1,711,963 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in GE HealthCare Technologies by 3.3% during the 1st quarter. Dimensional Fund Advisors LP now owns 4,943,579 shares of the company’s stock valued at $398,975,000 after purchasing an additional 157,839 shares in the last quarter. Canada Pension Plan Investment Board boosted its position in GE HealthCare Technologies by 15.2% in the 1st quarter. Canada Pension Plan Investment Board now owns 3,111,398 shares of the company’s stock valued at $251,121,000 after buying an additional 409,636 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in GE HealthCare Technologies by 3.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 3,069,114 shares of the company’s stock valued at $247,708,000 after buying an additional 109,858 shares during the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have commented on GEHC shares. Citigroup lowered GE HealthCare Technologies from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $93.00 to $83.00 in a research report on Tuesday, October 7th. BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research report on Wednesday. Zacks Research lowered GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Weiss Ratings reiterated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Tuesday, October 14th. Finally, Evercore ISI increased their price objective on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research report on Thursday. Six equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $86.10.

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $74.95 on Friday. The company has a market capitalization of $34.14 billion, a PE ratio of 15.49, a PEG ratio of 2.84 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.93 and a debt-to-equity ratio of 0.83. The stock’s fifty day simple moving average is $75.09 and its 200 day simple moving average is $73.06.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue was up 5.8% compared to the same quarter last year. During the same quarter last year, the business posted $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, October 24th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 2.87%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.